Clinical Trial Update: Antipsychotic Discontinuation in Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on discontinuation of an antipsychotic in Alzheimer's disease with psychotic symptoms; results have been posted. The conditions in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggression
• Agitation
• Alzheimer Disease
• Psychotic Disorders

Drugs mentioned

• Unspecified antipsychotic

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Alzheimer Disease, Psychotic Disorders | Phase 4 | Status: COMPLETED | Results posted: 2013-04-24